Pubblicazioni

Gadoteridol-enhanced MRI of the breast: can contrast agent injection rate impact background parenchymal enhancement?

2021 - ACTA RADIOLOGICA

Marzocca, F.; Moffa, G.; Landi, V. N.; Panzironi, G.; Kirchin, M. A.; Pediconi, F.; Galati, F.

Cardiac magnetic resonance in Takotsubo syndrome: welcome to mapping, but long live late gadolinium enhancement

2020 - INTERNATIONAL JOURNAL OF CARDIOLOGY

Arcari, Luca; Cacciotti, Luca; Camastra, Giovanni; Ciolina, Federica; Danti, Massimiliano; Sbarbati, Stefano; Ansalone, Gerardo

MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis

2019 - NEURORADIOLOGY

Cocozza, Sirio; Pontillo, Giuseppe; Lanzillo, Roberta; Russo, Camilla; Petracca, Maria; Di Stasi, Martina; Paolella, Chiara; Vola, Elena Augusta; Criscuolo, Chiara; Moccia, Marcello; Lamberti, Anna; Monti, Serena; Brescia Morra, Vincenzo; Elefante, Andrea; Palma, Giuseppe; Tedeschi, Enrico; Brunetti, Arturo

Reply to Radbruch et al.: "interpreting signal-intensity ratios without visible T1 hyperintensities in clinical gadolinium retention studies"

2017 - PEDIATRIC RADIOLOGY

Rossi Espagnet, Maria Camilla; TomÃ , Paolo; Napolitano, Antonio

T1 mapping and survival in systemic light-chain amyloidosis

2015 - EUROPEAN HEART JOURNAL

Banypersad, Sanjay M.; Fontana, Marianna; Maestrini, Viviana; Sado, Daniel M.; Captur, Gabriella; Petrie, Aviva; Piechnik, Stefan K.; Whelan, Carol J.; Herrey, Anna S.; Gillmore, Julian D.; Lachmann, Helen J.; Wechalekar, Ashutosh D.; Hawkins, Philip N.; Moon, James C.